These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21279523)

  • 41. Role of omalizumab in insulin hypersensitivity: a case report and review of the literature.
    Mishra S; Connors L; Tugwell B
    Diabet Med; 2018 May; 35(5):663-666. PubMed ID: 29381818
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving treatment satisfaction and other patient-reported outcomes in people with type 2 diabetes: the role of once-daily insulin glargine.
    Bradley C; Gilbride CJ
    Diabetes Obes Metab; 2008 Jul; 10 Suppl 2():50-65. PubMed ID: 18577157
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Insulin allergy (author's transl)].
    Vermeulen C
    Sem Hop; 1981 Oct 8-15; 57(37-38):1527-34. PubMed ID: 6270821
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A rational clinical approach to suspected insulin allergy: status after five years and 22 cases.
    Bodtger U; Wittrup M
    Diabet Med; 2005 Jan; 22(1):102-6. PubMed ID: 15606700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin allergy and immunologic insulin resistance.
    Davidson JK
    Compr Ther; 1982 Jan; 8(1):46-52. PubMed ID: 7039947
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment with human analog (GlyA21, ArgB31, ArgB32) insulin glargine (HOE901) resolves a generalized allergy to human insulin in type 1 diabetes.
    Moriyama H; Nagata M; Fujihira K; Yamada K; Chowdhury SA; Chakrabarty S; Jin Z; Yasuda H; Ueda H; Yokono K
    Diabetes Care; 2001 Feb; 24(2):411-2. PubMed ID: 11213905
    [No Abstract]   [Full Text] [Related]  

  • 48. Successful Treatment of Insulin Allergy with Desensitization Therapy: A Case Report and Literature Review.
    Elfekih H; Hadjkacem F; Elleuch M; Ghorbel D; Charfi N; Mnif F; Rekik N; Mnif M; Abid M
    Iran J Allergy Asthma Immunol; 2019 Oct; 18(5):572-583. PubMed ID: 32245301
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Desensitization for insulin allergy: a useful treatment also for local forms.
    Eguíluz-Gracia I; Rodríguez-Alvarez M; Cimarra-Alvarez M; Sanabria-Pérez MC; Martínez-Cócera C
    J Investig Allergol Clin Immunol; 2012; 22(3):215-6. PubMed ID: 22697012
    [No Abstract]   [Full Text] [Related]  

  • 50. Insulin allergy; desensitization with crystalline zinc-insulin and steroid tapering.
    Yokoyama H; Fukumoto S; Koyama H; Emoto M; Kitagawa Y; Nishizawa Y
    Diabetes Res Clin Pract; 2003 Sep; 61(3):161-6. PubMed ID: 12965105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Failure of multiple therapies in the treatment of a type 1 diabetic patient with insulin allergy: a case report.
    Koroscil T; Kagzi Y; Zacharias D
    Endocr Pract; 2011; 17(1):91-4. PubMed ID: 20713334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin allergy treated with human insulin (recombinant DNA).
    De Leeuw I; Delvigne C; Bekaert J
    Diabetes Care; 1982; 5 Suppl 2():168-70. PubMed ID: 6765530
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gallbladder edema in type 1 diabetic patient due to delayed-type insulin allergy.
    Kawasaki F; Kamei S; Tatsumi F; Hamamoto S; Shimoda M; Tawaramoto K; Shigeto M; Kanda Y; Hashiramoto M; Matsuki M; Kaku K
    Intern Med; 2009; 48(17):1545-9. PubMed ID: 19721301
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Urticaria after subcutaneous administration of Insulatard].
    Hruz P; Stöckli R; Bircher A
    Praxis (Bern 1994); 2007 May; 96(19):781-2. PubMed ID: 17571635
    [No Abstract]   [Full Text] [Related]  

  • 55. Allergic reactions to human insulin: a review of current knowledge and treatment options.
    Akinci B; Yener S; Bayraktar F; Yesil S
    Endocrine; 2010 Feb; 37(1):33-9. PubMed ID: 19876775
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case of insulin allergy: the crystalline human insulin may mask its antigenicity.
    Takatsuki H; Ishii H; Yamauchi T; Nakashima N; Nagase S; Hisatomi A; Umeda F; Nawata H
    Diabetes Res Clin Pract; 1991 May; 12(2):137-9. PubMed ID: 1879305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Human insulin allergy-immediate and late type III reactions in a long-standing IDDM patient.
    Silva ME; Mendes MJ; Ursich MJ; Rocha DM; Brito AH; Fukui RT; Ruggeri GB; Nery M; Wajchenberg BL
    Diabetes Res Clin Pract; 1997 May; 36(2):67-70. PubMed ID: 9229189
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug allergy.
    Blaiss MS; deShazo RD
    Pediatr Clin North Am; 1988 Oct; 35(5):1131-47. PubMed ID: 2971921
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Type III Hypersensitivity Reaction to Subcutaneous Insulin Preparations in a Type 1 Diabetic.
    Murray BR; Jewell JR; Jackson KJ; Agboola O; Alexander BR; Sharma P
    J Gen Intern Med; 2017 Jul; 32(7):841-845. PubMed ID: 28337685
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A case of primary and generalized allergy to human insulin with no history of any prior insulin exposure.
    Takuma H; Kawagishi T; Kyogoku I; Okuno Y; Nishizawa Y; Morii H
    Diabetes Res Clin Pract; 1995 Oct; 30(1):69-73. PubMed ID: 8745208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.